(Q36946576)

English

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

scientific article published on 20 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

World Health Organization

0 references

0 references

1

object named as

Tefferi A

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

James W Vardiman

2

object named as

Vardiman JW

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

14-22

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404955

0 references

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenes in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloproliferative disorders: a tyrosine kinase tale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative review of classification systems in myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal origin of chronic myelocytic leukemia in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycythemia vera: stem-cell and probable clonal origin of the disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of clonality in chronic neutrophilic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 V617F due to a novel TG --> CT mutation at nucleotides 1848-1849: diagnostic implication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F mutation is absent in patients with erythrocytosis due to high oxygen affinity hemoglobin variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F mutation is rare in RARS but common in RARS-T

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the JAK2 V617F mutation is not found in de novo AML and MDS but is detected in MDS-derived leukemia of megakaryoblastic nature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F mutation in de novo acute myelogenous leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening of JAK2 V617F mutation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Should a platelet limit of 600 x 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Apparent polycythaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Inapparent polycythemia vera: an unrecognized diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2(V617F)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopathologic findings in chronic idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The haematocrit and platelet target in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological and cytological heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Eosinophilia: secondary, clonal and idiopathic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Inherited predispositions and hyperactive Ras in myeloid leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic interface between histology and molecular tests in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2V617F is infrequently associated with arterial stroke in the absence of overt myeloproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404955

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404955

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36946576&oldid=1664387068"